Healthcare providers & services stocks Q3 teardown: AMN Healthcare Services vs the rest
This article provides a Q3 earnings teardown for healthcare providers and services stocks, focusing on AMN Healthcare Services and its peers. It details AMN Healthcare Services' strong revenue beat and positive outlook, contrasting it with top performer LifeStance Health Group and weakest performer Brookdale Senior Living. The analysis also covers Tenet Healthcare and Centene, highlighting key financial results and market reactions for each company.
Ameriprise reports shares in AMN Healthcare (AMN) but disclaims beneficial ownership.
Ameriprise Financial, Inc. reported beneficial ownership of 1,939,466 shares, or 5.0%, of AMN Healthcare Services, Inc. common stock as of September 30, 2026, in a Schedule 13G filing. Despite the reported ownership, Ameriprise explicitly disclaims beneficial ownership of these shares. The filing details shared voting power over 1,933,086 shares and shared dispositive power over 1,939,466 shares, with no sole voting or dispositive power.
How Stronger Earnings At AMN Healthcare Services (AMN) Has Changed Its Investment Story
AMN Healthcare Services reported stronger third-quarter 2026 sales and a shift to net income for the first nine months, indicating improved profitability despite a tough market. The company's updated fourth-quarter guidance for a narrow operating margin will be key in determining if this profitability trend is sustainable amidst ongoing pressures in some segments. Analysts' existing forecasts, which anticipate revenue and earnings declines, may need adjustment as this new financial information is absorbed by the market.
We Think AMN Healthcare Services' (NYSE:AMN) Profit Is Only A Baseline For What They Can Achieve
Despite reporting strong earnings, AMN Healthcare Services (NYSE:AMN) investors seemed underwhelmed. However, an analysis of the accrual ratio from cashflow reveals that the company's free cash flow significantly exceeded its statutory profit, suggesting its reported profit may actually understate its true earnings potential. The company's positive free cash flow, especially after losing money last year, indicates a promising financial outlook.
Here's Why You Should Retain AMN Stock in Your Portfolio for Now
AMN Healthcare Services, Inc. (AMN) is expected to grow due to strong demand in nurse and allied staffing, opportunities in Managed Services Programs (MSPs), and investments in technology. Despite these positives, the company faces headwinds from pricing pressure, competitive challenges, visa appointment delays for international nurses, and weakness in its Physician and Technology businesses. Analysts project significant earnings growth for 2026, and the stock has outperformed the industry year-to-date.
AMN Healthcare Services, Inc. (AMN) Stock Price, News, Quote & History
This page provides a comprehensive overview of AMN Healthcare Services, Inc. (AMN) stock, including its current price, news, and historical data. Recent articles highlight strong Q3 2026 results, analyst upgrades, and discussions around the stock's valuation. The performance overview shows significant year-to-date and one-year returns for AMN, outperforming the S&P 500.
BofA raises AMN Healthcare stock price target on revenue beat
BofA Securities raised its price target for AMN Healthcare Services Inc (NYSE:AMN) to $34.50 from $28.00 while maintaining an Underperform rating, following the company's third-quarter revenue beat. Despite the revenue outperformance, BofA lowered its 2027 and 2028 EBITDA estimates due to a lower starting point and cautioned that the current valuation already reflects an accelerating growth profile. However, InvestingPro data suggests the stock may still be undervalued based on its Fair Value analysis, with an attractive PEG ratio.
AMN Healthcare Services (AMN) stock trades down, here is why
Shares of AMN Healthcare Services (AMN) fell 22.6% after the company forecasted a 10% to 12% year-over-year revenue decline for the fourth quarter in its third-quarter 2026 earnings release. The company projected fourth-quarter consolidated revenue between $655 million and $670 million and reported Q3 2026 revenue of $717.3 million, up 13% year over year. Despite a significant year-to-date gain, the stock is trading below its 52-week high, and long-term investors have seen a substantial decrease in their investment.
An $88M year-earlier loss gives way to a nine-month profit at AMN Healthcare (AMN).
AMN Healthcare Services, Inc. reported a significant turnaround, moving from an $88.0 million net loss in the first nine months of the previous year to a net income of $116.7 million for the nine months ended September 30, 2026. This profit was driven by a 40% increase in revenue to $2,768.9 million, largely due to a substantial rise in labor disruption services revenue within its nurse and allied solutions segment. The company also saw a 13% increase in third-quarter revenue and improved gross margins due to reserve releases and billing settlements.
How Investors May Respond To AMN Healthcare Services Stock After Profit Turnaround
AMN Healthcare Services reported a significant profit turnaround in the third quarter and first nine months of 2026, with net income reaching US$116.72 million year-to-date. This shift is crucial for its investment narrative, suggesting that sustained profitability from flexible staffing and permanent hires in hospitals could offset pressures in other segments. While the profit rebound provides financial flexibility for tech investments, concerns regarding high debt, one-off items, and softer demand in specific solutions persist, framing future execution challenges for the company.
AMN Healthcare Services Q3 2026 Earnings Call Transcript
AMN Healthcare Services reported strong Q3 2026 results with revenue up 13% year-over-year to $717 million, driven by growth in its Nurse and Allied segment and Search revenue. The company is strategically focused on technology-enabled solutions to meet the increasing demand for flexible healthcare workforce solutions, despite challenges in its international nurse business due to visa delays. AMN projects Q4 revenue between $655 million and $670 million and anticipates continued growth in 2027, particularly in Nurse and Allied and Locum tenens, supported by AI-driven recruitment and process improvements.
AMN Healthcare Services (NYSE:AMN) delivers strong Q3 2026 numbers, next quarter’s sales guidance is optimistic
AMN Healthcare Services (NYSE: AMN) reported strong Q3 2026 results, exceeding revenue and adjusted EPS expectations, with revenue up 13% year-on-year to $717.3 million. The company's Q4 2026 revenue guidance is also optimistic, surpassing analysts' consensus estimates. Despite positive quarterly performance, the stock fell 3.8% immediately after the announcement, and analysts anticipate revenue and EPS declines over the next 12 months, raising questions about future demand and profitability.
AMN Healthcare Services Inc (AMN) Tops Q3 EPS by 93c ; Offers Guidance
AMN Healthcare Services Inc (AMN) reported strong Q3 results, with EPS of $1.16, significantly beating analyst estimates of $0.23. The company also surpassed revenue expectations, bringing in $717.3 million against a consensus of $648.93 million. Furthermore, AMN Healthcare provided optimistic Q4 2026 revenue guidance of $655-670 million, exceeding the consensus of $653.8 million.
AMN Healthcare Services, Inc. (AMN) Seasonal returns chart
This article provides a seasonal returns chart for AMN Healthcare Services, Inc. (AMN), detailing the average monthly price return from 2016 to 2026. It includes current stock information, a link to the Q3 2026 earnings call, and options to view historical data, financials, and analyst insights.
AMN Healthcare Services (AMN), What Is Drawing Fresh Attention Now?
AMN Healthcare Services (AMN) has recently experienced a sharp rebound in share price, with significant gains over the past one and three months, despite longer multi-year declines. The stock is currently trading above its analyst target and intrinsic value, leading to a "30% overvalued" narrative. While the P/E ratio appears cheaper than rivals, it is still much higher than its fair ratio, suggesting valuation risk.
Technical Reactions to AMN Trends in Macro Strategies
This article provides a technical analysis of AMN Healthcare Services Inc (NYSE: AMN), identifying weak near-term sentiment but no clear price positioning signal. It highlights compelling upside potential due to the absence of resistance levels above the current price. The analysis offers three AI-generated trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss zones, alongside a multi-timeframe signal analysis.
AMN Q3'26 Earnings: revenue estimate is 649.55M USD
AMN Healthcare Services Inc (AMN) is scheduled to release its Q3'26 financial results on November 5, after market close, with earnings expected at 4:15 PM ET (9:15 PM UTC). Analysts estimate revenue for the quarter to be $649.55 million USD and earnings per share (EPS) at $0.23 USD. The article provides a table detailing historical reported and estimated revenues and EPS, including surprise percentages for previous quarters.
AMN Healthcare Services Inc (AMN) Stock Price | Live Quotes & Charts | NYSE
This page provides live quotes and charts for AMN Healthcare Services Inc (AMN) stock, showing its current price, daily change, and percentage change. It also includes sections for analyst ratings and earnings information, although no analyst ratings or earnings data are currently available. The article offers a basic overview of the stock's market performance.
Enterprise value to EBITDA forward of AMN Healthcare Services, Inc. – FWB:HCQ
This article provides an overview of AMN Healthcare Services, Inc. (FWB: HCQ) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to EBITDA forward metric. The page indicates that the market is currently closed with no trades. It also highlights the various data sources and copyrights associated with the financial information presented.
AMN Healthcare Services stock hits 52-week high at 47.36 USD
AMN Healthcare Services Inc. has reached a new 52-week high of $47.36, trading just 1% below its peak. The stock has seen a significant 197% return year-to-date and a 122.25% increase over the past year, driven by high demand for healthcare professionals. InvestingPro analysis suggests the company is undervalued, with an attractive PEG ratio and strong recent earnings.
AMN Healthcare Services stock hits 52-week high at 47.36 USD
AMN Healthcare Services Inc. (AMN) stock has reached a new 52-week high of $47.36, representing a 197% year-to-date return and a 122.25% one-year change, driven by high demand for healthcare professionals. InvestingPro analysis suggests the stock is undervalued, with a low PEG ratio of 0.13. The company also recently reported strong Q2 2026 earnings, exceeding Wall Street estimates, and Truist Securities maintained a Buy rating.
AMN Healthcare Services, Inc. Estimates – LSX:798185
This page on TradingView provides financial estimates and actual data for AMN Healthcare Services, Inc. (LSX:798185). Users can explore reported financial data and analyst estimates across various financial statements, compare results with average, high, and low estimates, and visualize trends over time. The platform includes disclaimers regarding investment advice.
AMN Healthcare Services stock hits 52-week high at 47.36 USD
AMN Healthcare Services (AMN) stock reached a new 52-week high of $47.36, trading just 1% below its peak and showing a 197% year-to-date return. The company's growth is attributed to increased demand for healthcare professionals, with InvestingPro analysis suggesting it is undervalued and poised for future performance. This follows a strong Q2 2026 earnings report and a maintained Buy rating from Truist Securities.
AMN Healthcare Services stock hits 52-week high at 47.36 USD
AMN Healthcare Services Inc. (AMN) stock reached a new 52-week high of $47.36, demonstrating a significant 197% year-to-date return and a 122.25% one-year change. This surge is attributed to increased demand for healthcare professionals and strong investor confidence. InvestingPro analysis suggests AMN is undervalued, with a low PEG ratio and recent Q2 2026 earnings exceeding expectations, further bolstered by a "Buy" rating from Truist Securities.
BMO raises AMN Healthcare stock target to USD 43.00
BMO Capital has raised its price target for AMN Healthcare Services (AMN) to $43.00 from $40.00, maintaining an Outperform rating. This adjustment follows AMN's strong Q2 2026 performance, where adjusted EPS significantly increased, and revenue grew by 2.00% year-over-year. The company is set to release its Q3 2026 results on November 5, 2026, which will further test the sustainability of its growth beyond nurse and allied staffing.
Gastroenterologists Overtake Orthopedic Surgeons as Highest-Paid Physician Recruits, AMN Healthcare Report Finds
According to AMN Healthcare's 33rd annual review, gastroenterologists now command the highest average starting salary for physicians at $654,000, surpassing orthopedic surgeons. The report highlights a significant increase in physician signing bonuses, up 29% to nearly $50,000, driven by intensifying competition for specialists due to an aging population. While specialists like interventional cardiologists and urologists see substantial salary gains, primary care physicians' salaries remain considerably lower.
AMN Healthcare Services schedules November 5 results for AMN stock
AMN Healthcare Services (AMN) has scheduled its third-quarter 2026 results release for November 5, 2026, after market close, with a conference call at 5:00 p.m. ET. The company's stock closed at USD 40.49 on October 16, 2026, up 1.23% on the NYSE, and is trading near its 52-week high after a significant year-to-date advance. This upcoming report will be a key event for investors to assess if operating trends support the current valuation, especially following BMO Capital's recent price target increase to USD 43.00 with an Outperform rating.
Form 4 AMN Healthcare Services Inc: Mark Christopher Hagan (Chief Information and Digital) For: 15 October
This article reports on a Form 4 filing for AMN Healthcare Services Inc., indicating activity by Mark Christopher Hagan, the Chief Information and Digital Officer, related to October 15th. The filing is a standard disclosure of insider transactions, as reported by Investing.com.
Form 4 AMN Healthcare Services Inc: Whitney M. Laughlin (CLO) For: 15 October
This article reports on a Form 4 filing for AMN Healthcare Services Inc. concerning Whitney M. Laughlin (CLO) for October 15. Form 4 filings disclose changes in beneficial ownership of securities by company insiders. The article indicates this is a routine financial disclosure related to insider trading activity.
BMO lifts target for AMN Healthcare stock to USD 43.00
BMO Capital has raised its price target for AMN Healthcare (AMN) stock from $40.00 to $43.00, maintaining an "Outperform" rating. This adjustment follows AMN's second-quarter revenue of $673.24 million, a 2.30% year-over-year increase, with the company scheduled to release its third-quarter results on November 5, 2026. The new target is 8.72% above the NYSE price, reflecting positive staffing industry metrics and potential for strong upcoming results.
AMN Healthcare Services stock reaches 52-week high at $38.47 By Investing.com
AMN Healthcare Services (AMN) stock has hit a new 52-week high of $38.47, reflecting a significant 91.97% 1-year change and approximately 139% year-to-date return. The company reported stronger-than-expected Q2 2026 results, with adjusted earnings of $0.77 per share and revenue of $673.2 million, surpassing analyst forecasts. Truist Securities maintained a Buy rating with a $40.00 price target, indicating continued confidence in the company's performance.
AMN Healthcare Services stock reaches 52-week high at $38.47 By Investing.com
AMN Healthcare Services (AMN) stock has hit a new 52-week high of $38.47, reflecting a significant 91.97% increase over the past year and a 139% year-to-date return. The company, with a market capitalization of $1.48 billion, is seen as undervalued by InvestingPro, trading at a P/E ratio of 13.93. This milestone follows stronger-than-expected Q2 2026 results and a maintained Buy rating from Truist Securities.
AMN Healthcare Services stock reaches 52-week high at $38.47
AMN Healthcare Services Inc. (AMN) stock has hit a 52-week high of $38.47, reflecting a 91.97% increase over the past year and a 139% year-to-date return. The company's strong performance is supported by better-than-expected Q2 2026 results and a maintained Buy rating from Truist Securities, which sees the stock as undervalued.
AMN Healthcare Services Inc. (HCQ.SG) Q2 FY2026 earnings call transcript
AMN Healthcare Services Inc. (HCQ.SG) reported stronger-than-forecast Q2 FY2026 results, with consolidated revenue up 2% year-over-year to $673 million and adjusted EBITDA rising 26% to $73 million. The company saw significant growth in its Nurse and Allied Solutions segment, driven by increased demand for travel nurses and allied professionals, and made strategic acquisitions to enhance its service offerings. Despite competitive pressures in some segments like language services, AMN Healthcare is optimistic about sustained demand, particularly for flexible labor, and its strong financial position to pursue further strategic growth.
Here's Why You Should Retain AMN Stock in Your Portfolio for Now
AMN Healthcare Services, Inc. (AMN) is positioned for growth due to increasing healthcare staffing demand and expanding technology-enabled workforce solutions. Despite potential challenges like pricing competition and uneven segment performance, the company's investments in AI and its strong market position suggest continued improvements. Analysts project significant earnings growth for 2026, reinforcing a "Hold" recommendation for the stock.
Here's Why You Should Retain AMN Stock in Your Portfolio for Now
AMN Healthcare Services, Inc. (AMN) is positioned for growth due to strong healthcare staffing demand, expanding technology-enabled solutions, and growth in higher-margin technology and language services. Despite facing challenges like pricing competition and weakness in its physician and technology businesses, the company maintains a Zacks Rank #3 (Hold) and shows strong earnings growth projections. Investors should consider retaining AMN stock in their portfolios given its favorable market position and expected business improvements.
AMN Healthcare Services Inc (AMN) Stock Forecasts
Argus has raised its target price for AMN Healthcare Services Inc (AMN) to $39.00, noting the company provides healthcare workforce solutions and staffing services in the United States. The current price for AMN stock is $36.28. This report is part of quantitative research reports offered to premium subscribers.
(AMN) Movement Within Algorithmic Entry Frameworks
This article analyzes Amn Healthcare Services Inc (NYSE: AMN), highlighting a mid-channel oscillation pattern and a significant 51.4:1 risk-reward setup. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis indicating varying signal strengths and key support/resistance levels.
BMO Capital Maintains AMN Healthcare Services(AMN.US) With Buy Rating, Raises Target Price to $43
BMO Capital has reiterated its Buy rating on AMN Healthcare Services (AMN.US) and increased its price target for the stock to $43. This indicates a continued positive outlook from the firm regarding the company's financial prospects and stock performance.
AMN Upgraded by BMO Capital -- Price Target Raised to $43.00
BMO Capital has upgraded AMN Healthcare Services (AMN) to "Outperform" and raised its price target to $43.00, indicating a positive outlook for the company's future performance. Despite the upgrade, GuruFocus assesses AMN as 23.6% overvalued with a GF Value™ of $29.53, suggesting investors might be paying a premium. The company's GF Score™ of 63/100 points to moderate financial health, with strengths in profitability and financial stability, but concerns about growth potential.
AMN Healthcare to report Q3 2026 results and Q4 outlook on Nov 5 with live webcast.
AMN Healthcare Services, Inc. will announce its third-quarter 2026 financial results and provide its outlook for the fourth quarter on November 5, 2026. The earnings news will be released after market close at approximately 4:15 p.m. Eastern Time, followed by a conference call at 5:00 p.m. ET, available via live webcast and telephone. This event is crucial for investors to understand AMN Healthcare's recent performance and future expectations within the healthcare staffing industry.
AMN Healthcare to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call for Thursday, November 5, 2026, at 5:00 p.m. Eastern Time, to discuss its third quarter 2026 financial results and fourth quarter 2026 outlook. The company will issue an earnings news release approximately 4:15 p.m. Eastern Time on the same day. Interested parties can access the live webcast or register for telephone participation through provided links on the company's investor relations website.
Third-quarter results and the fourth-quarter outlook are on AMN Healthcare's Nov. 5 call.
AMN Healthcare Services (NYSE: AMN) has scheduled its third-quarter 2026 earnings conference call for November 5, 2026, at 5:00 p.m. Eastern Time. The company will release its earnings after market close on the same day, around 4:15 p.m. ET, and the call will cover quarterly financial results and the fourth-quarter 2026 outlook. A live webcast and replay will be available via its investor relations website.
AMN Healthcare to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call for Thursday, November 5, 2026, at 5:00 p.m. Eastern Time, to discuss its third quarter 2026 financial results and fourth quarter 2026 outlook. The company will also release its earnings news after market close at approximately 4:15 p.m. Eastern Time on the same day. Interested parties can access a live webcast or register to participate via telephone.
11 of 12 hospital tech measures were associated with better patient experience.
AMN Healthcare's research, based on a study of over 2,000 hospitals, found a strong link between digital investment and improved patient experience and efficiency. Specifically, 11 of 12 digital measures correlated with better patient experience, and 9 of 12 with better efficiency. While established enterprise systems showed consistent positive associations, AI's impact on patient experience and efficiency was less consistent, and greater transformation intensity was sometimes associated with worse efficiency in midsize hospitals.
AMN Healthcare Research Links Hospital Digital Investment to Better Patient Experience
New research from AMN Healthcare indicates a strong correlation between digital investment in hospitals and improved patient experience. The study, involving over 2,000 hospitals, found that 11 of 12 digital footprint measures were linked to better patient experience, and 9 of 12 to better efficiency, with enterprise systems showing the most consistent positive performance associations. The findings emphasize that successful digital transformation relies not just on technology, but also on strong leadership, governance, redesigned workflows, and clinician engagement, suggesting that organizational readiness is key to converting digital investments into value.
AMN Healthcare Services stock hits 52-week high at 37.3 USD
AMN Healthcare Services Inc. (AMN) stock reached a 52-week high of $37.22, currently trading at $37.46, reflecting an 86% increase over the past year and 134% year-to-date. This surge follows strong Q2 2026 financial results, where the company surpassed analyst expectations with adjusted earnings of $0.77 per share and revenue of $673.2 million, leading Truist Securities to maintain a Buy rating with a $40 price target.
AMN Healthcare Services stock hits 52-week high at 37.3 USD
AMN Healthcare Services Inc. (AMN) stock reached a new 52-week high of $37.22, with shares currently trading at $37.46, reflecting an 86% increase over the past year and 134% year-to-date. This surge follows robust second-quarter 2026 financial results, where the company surpassed Wall Street expectations with adjusted earnings of $0.77 per share and revenues of $673.2 million. Truist Securities maintained a Buy rating on AMN Healthcare with a $40.00 price target, underscoring analyst confidence and the company's strong growth in the healthcare services sector.
AMN Healthcare to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) will host a conference call on Thursday, November 5, 2026, at 5:00 p.m. Eastern Time to discuss its third quarter 2026 financial results and provide a fourth quarter 2026 outlook. An earnings news release is expected to be issued earlier that day, around 4:15 p.m. Eastern Time. A live webcast and replay of the call will be accessible via the company's investor relations website.
ETFs Investing in AMN Healthcare Services, Inc. Stocks
This article lists various ETFs that include AMN Healthcare Services, Inc. (AMN) stocks in their holdings. The ETFs are primarily small-cap focused, with some also targeting value, momentum, or healthcare sectors. Key details such as market value, weight of AMN in the ETF, issuer, management style, expense ratio, and 3-year total return are provided for each fund.